In agreement with a significant upregulation of NR0B2 gene expression in colon and B-cell lymphoma (Table S2), higher NR0B2 expression levels were significantly associated with worse overall survival in these patients (Figures 3H, I). This evidence concerns the gene NR0B2 and B-cell non-Hodgkin lymphoma.